Catalent (CTLT) Reports Q3 Loss, Misses Revenue Estimates

Catalent (CTLT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.24. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -125%. A quarter ago, it was expected that this maker of drug delivery technologies would post a loss of $0.03 per share when it actually produced a loss of $0.24, delivering a surprise of -700%.Over the last four quarters, the company has ...